We are live on
!
Find out more
Corcept Therapeutics
CORT
CORT
422 hedge funds and large institutions have $9.24B invested in Corcept Therapeutics in 2025 Q1 according to their latest regulatory filings, with 103 funds opening new positions, 129 increasing their positions, 144 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
220% more funds holding in top 10
Funds holding in top 10: 5 → 16 (+11)
151% more first-time investments, than exits
New positions opened: 103 | Existing positions closed: 41
118% more capital invested
Capital invested by funds: $4.25B → $9.24B (+$5B)
15% more funds holding
Funds holding: 367 → 422 (+55)
1.56% less ownership
Funds ownership: 80.42% → 78.86% (-1.6%)
10% less repeat investments, than reductions
Existing positions increased: 129 | Existing positions reduced: 144
42% less call options, than puts
Call options by funds: $193M | Put options by funds: $335M
Holders
422
Holders Change
+55
Holders Change %
+14.99%
% of All Funds
5.66%
Holding in Top 10
16
Holding in Top 10 Change
+11
Holding in Top 10 Change %
+220%
% of All Funds
0.21%
New
103
Increased
129
Reduced
144
Closed
41
Calls
$193M
Puts
$335M
Net Calls
-$142M
Net Calls Change
-$127M
Top Buyers
| 1 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
+$36.3M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$32.9M |
| 3 |
Man Group
London,
United Kingdom
|
+$20.8M |
| 4 |
Morgan Stanley
New York
|
+$16.9M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$15.8M |
Top Sellers
| 1 |
BlackRock
New York
|
-$60.2M |
| 2 |
ISL
Ingalls & Snyder LLC
New York
|
-$21.7M |
| 3 |
BTW
Boston Trust Walden
Boston,
Massachusetts
|
-$19.1M |
| 4 |
SAM
Synergy Asset Management
Vancouver,
Washington
|
-$17.8M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
-$17.7M |
